Suvretta Capital Management’s Merck MRK Stock Holding History

Suvretta Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-219,178	Closed	-$18.4M	–	100
2025 Q3	$18.4M	Hold	219,178	–	–	0.47%	57
2025 Q2	$17.4M	Buy	219,178 +75,078	+52%	+$5.97M	0.52%	46
2025 Q1	$12.9M	Buy	144,100 +91,100	+172%	+$8.51M	0.48%	52
2024 Q4	$5.27M	Buy	+53,000	New	+$5.46M	0.18%	64
2024 Q1	–	Sell	-15,500	Closed	-$1.69M	–	109
2023 Q4	$1.69M	Buy	+15,500	New	+$1.61M	0.08%	68
2018 Q4	–	Sell	-3,953,601	Closed	-$268M	–	32
2018 Q3	$268M	Buy	3,953,601 +1,872,140	+90%	+$119M	6.16%	7
2018 Q2	$121M	Buy	+2,081,461	New	+$117M	3.2%	15
2016 Q4	–	Sell	-1,766,299	Closed	-$105M	–	58
2016 Q3	$105M	Buy	+1,766,299	New	+$103M	3.38%	10

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Suvretta Capital Management's MRK Position: Q4 2025 in Review

Suvretta Capital Management sold out of Merck (MRK) in Q4 2025, closing a stake of 219,178 shares — an estimated $18.4M sold.

Suvretta Capital Management first reported a position in MRK in Q3 2016 and held it in 8 quarters. The position peaked at $268M in Q3 2018. 3,651 funds tracked by Wall St. Rank hold MRK as of Q4 2025.

Suvretta Capital Management reported no remaining Merck position as of Q4 2025 after selling out during the quarter.
Suvretta Capital Management sold 219,178 Merck shares in Q4 2025, an estimated $18.4M.
Suvretta Capital Management first reported a position in Merck in Q3 2016 and held it in 8 quarters.
Suvretta Capital Management's Merck position peaked at $268M in Q3 2018.
3,651 funds tracked by Wall St. Rank held Merck as of Q4 2025.

Based on Suvretta Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.